Navigation Links
American Heart Association Late-Breaking Clinical Trial Report: New Reversible Antiplatelet Drug no More Effective Than Irreversible One in PCI
Date:11/15/2009

pproved antiplatelet drug that binds irreversibly to platelets.

Those in the cangrelor group got 30 micrograms (mcg) of cangrelor per kilogram (kg) of body weight intravenously, followed by a 4 mcg/kg/per minute infusion for at least two hours. At the end of the procedure, they received a 600 milligram (mg) dose of clopidogrel.

Patients in the clopidogrel group received a standard 600 mg loading dose immediately prior to their PCI. Following the procedure all patients received a maintenance dose of 75 mg of clopidogrel and aspirin therapy (75 mg to 325 mg/day) for at least 30 days thereafter.

Patients received all other anti-clotting therapies according to care standards at their treatment site.

"There was no statistically significant difference in the primary composite endpoint (death, heart attack and ischemic revascularization at 48 hours), which affected 7.5 percent of the cangrelor group vs. 7.1 percent for the clopidogrel group," Harrington said. But, in formal non-inferiority 1160 testing, cangrelor appeared to maintain more than 60 percent of the benefit of 600 (mg) clopidogrel over placebo.

When looked at together with data from the companion trial, researchers also found a reduction in acute stent thrombosis, which are blood clots within the metal mesh stent implanted during PCI to help hold the vessel open. The two treatment groups were well balanced in baseline characteristics. It was noted that there was more minor bleeding associated with cangrelor.

This is the first study to use a 600-mg dose (instead of 300-mg dose) of clopidogrel as the comparison drug and to compare that dose to cangrelor. Cangrelor is the first drug in a class of intravenous P2Y12 receptor antagonists. It provides immediate and intense inhibition of platelet clotting, but, as opposed to clopidogrel, this effect can be reversed.

"With its fast onset and reversibility, cangrelor holds the potent
'/>"/>

SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Viron to Present Data from Phase II Trial at American Heart Association Conference
2. MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology
3. Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix
4. Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
5. Bionovo to Present on Novel Female-Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society
6. American Capital Receives $182 Million In Proceeds From Sale of Axygen Bioscience
7. American Oriental Bioengineering Announces September Investor Conferences Participation
8. American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device
9. American Oriental Bioengineerings Jinji Capsules and Boke Nasal Spray Designated Among Chinas Top Branded Drugs of 2009
10. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
11. American Oriental Bioengineering Announces Change in Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 This is a ... of the Phenolic Resin industry in Global and ... industry, including definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
(Date:9/23/2014)... de Reuil, France (PRWEB) September 23, 2014 ... to protection of laboratory personnel since 1968 and Burdinola, ... the development of a new filtered fume hood. ... above their laboratory fume hood, Burdinola will now offer ... for filtering a wide range of chemicals, best-in-class detection ...
(Date:9/23/2014)... Proove Biosciences , the commercial and research ... the association between specific genes and patients’ predisposition to ... Health Congress’ 27th Annual Scientific Program in Orlando, ... of ‘Embracing Change.’ Mental health, and healthcare as a ... challenges presented by the Affordable Care Act to the ...
(Date:9/23/2014)... Sept. 23, 2014 Research and ... "Proteomics Markets for Research and IVD Applications (Mass ... report to their offering. This ... applications, both in their research use and in ... the study of the structure and function of ...
Breaking Biology Technology:Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 2Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 4
... The power to edit genes is as revolutionary, immediately ... Gutenberg,s printing press. And like Gutenberg,s invention, most DNA ... brilliant technology in its infancy. Now, Harvard researchers developing ... processing have rewritten the genome of living cells using ...
... Neogen Corporation (NASDAQ: NEOG ) announces ... , Tuesday, July 26, 2011 @ 11:00 ETWhere: , ... -- Simply log on to the web at the ... Corporation, +1-800-234-5333If you are unable to participate during the ...
... time that the hormone leptin acts in the brain to ... mystery. Now, new research published by Cell Press in the ... neurobiological mechanisms that may underlie the antiobesity effects of leptin. ... cells and acts at its receptor in the brain to ...
Cached Biology Technology:Editing the genome 2Editing the genome 3Modulation of inhibitory output is key function of antiobesity hormone 2
(Date:9/23/2014)... more carbon than the atmosphere and small changes ... effect on atmospheric greenhouse gas concentrations. A new ... concludes that climate warming does not accelerate ... storage, despite increases in ecosystem productivity. , ... Ecologist Dr. Christian Giardina, with the agency,s Institute ...
(Date:9/23/2014)... funds to support the next phase of its Tissue ... predicting drug safety and effectiveness. Researchers will collaborate over ... and combine them into an integrated system that can ... by the National Center for Advancing Translational Sciences (NCATS), ... in 2014 with additional support over the remaining two ...
(Date:9/23/2014)... tissues during the healing process, cells must be ... scientists believed this communication happened primarily through chemical ... the University of Pittsburgh have found that another ... not more crucial. The findings, published in this ... National Academy of Sciences , could lead to ...
Breaking Biology News(10 mins):Study helps assess impact of temperature on belowground soil decomposition 2NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4The mechanics of tissue growth 2
... 20 years have suggested (though not unequivocally,confirmed) that semen ... sperm counts and,reduced sperm motility.(1) The explanations have been ... and to male smoking. Now, a new study,based on ... study cohorts, suggests that,exposure to several factors in utero ...
... with thinner roots can grow deeper, a trait which could ... New research, to be presented at the Society for Experimental ... have fewer cortical cells in the outer layer of their ... A research team headed by Prof Jonathan Lynch at the ...
... in Antarctica, is so dark, deep and cold that scientists ... place where nothing could live. However, work by Dr. ... sciences, and his colleagues has revealed a surprising variety of ... environments. A paper published June 26 in PLOS ONE ...
Cached Biology News:Early life and in utero factors found to influence testicular function in adulthood 2Early life and in utero factors found to influence testicular function in adulthood 3In subglacial lake, surprising life goes on 2In subglacial lake, surprising life goes on 3In subglacial lake, surprising life goes on 4In subglacial lake, surprising life goes on 5
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2...
... - 5 units/µL ,• High specific activity ... Leaves an 'A' overhang ,• Processes ... very high activity in primer extension and ... quality of the enzyme, each lot has ...
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/uL; 25 tubes of 1, 000 units enzyme/tube w/ Buffer I...
... Gold® DNA Polymerase is a chemically modified ... chemical moiety is attached to the enzyme, ... the first ramp of thermal cycling (when ... temperatures), the enzyme is inactive. The result ...
Biology Products: